RT Journal Article
SR Electronic
A1 Alexander, Lori
T1 Novel Agent Found to Reduce HbA1C in Type 2 Diabetes
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 8
SP 13
OP 14
DO 10.1177/155989771108007
UL http://mdc.sagepub.com/content/11/8/13.abstract
AB A randomized, double-blind, multicenter study demonstrated that a G-protein-coupled receptor 40 (GPR40) agonist had glucose-lowering efficacy for the treatment of type 2 diabetes. The novel agent significantly reduced HbA1C compared with placebo, with efficacy that was comparable with glimepiride but with a significantly lower rate of hypoglycemia.